The Relationship Between Surgical Volume and Patient Outcomes in Urologic Malignancies
|
|
- Hugo Marsh
- 5 years ago
- Views:
Transcription
1 The Relationship Between Surgical Volume and Patient Outcomes in Urologic Malignancies Geoffrey Gotto PGY-5 UBC Department of Urologic Sciences October 8 th, 2008 Objective To review the literature on the relationship between provider volume and outcomes in surgery for urologic malignancies 1
2 Rationale Growing interest in health-outcomes research (esp. in US) Medico-legal accountability Cost-containment A direct association exists between provider volume and improved outcomes in a number of surgical procedures CABG Pancreatic cancer Esophageal cancer etc. The magnitude of the association varies according to the procedure Major consequences in terms of health policy initiatives What is high volume? 2
3 Henry Ford ( ) Born in Dearborn, Michigan Chief Engineer for the Edison Illuminating Co. Founder of the Ford Motor Co. Father of modern assembly lines Fordism Mass production of numbers of automobiles using the assembly line, coupled with high wages for workers 3
4 Does quantity equal quality? 4
5 5
6 Learning (Experience) Curves Definition Efficiencies that arise from the learning and experience gained from repeated activities 1 st described by Herman Ebbinghaus in 1885 Mathematical model described by Theodore Paul Wright in
7 Chuck Learning (Experience) Curves Explanations Labour efficiency Standardization, specialization, and methods improvements Technology-Driven Learning Automated production Information technology Better use of equipment Product redesign Value chain effects (suppliers + distributors) Network-building and use-cost reductions Shared experience effects 7
8 Economies of Scale Definition Efficiencies that arise from an increased scale of production Coalition of 150 US health care purchasers insuring over 34 million people Encourages high-volume providers for complex surgery 4 Leaps 1. Computer Physician Order Entry (CPOE) 2. Evidence-Based Hospital Referral 3. ICU Physician Staffing 4. Leapfrog Safe Practices Score 8
9 If the 1 st 3 leaps were implemented... 65,000 lives saved (Birkmeyer 2004) 907,000 medication errors avoided (Birkmeyer 2004) $41.5 billion saved (Conrad 2005) Implementing practices to inform patients regarding Hospital Volume Outcomes Surgeon Volume Outcomes 9
10 CABG RAMR > Average for 47% of high-volume hospitals (>500/yr) 33% of high-volume surgeons (>150/yr) 10
11 Lessons From Other Specialties 12 surgical 1498 hospitals Case mix adjustment Mortality 25-41% with 200 cases / hospital / yr OHS CABG Vascular surgery THR TURP No change in mortality for Cholecystectomy 11
12 Design Systematic Medline review ( ) MeSH search algorithm terms Outcome, Outcome assessment, Process assessment, Volume, Utilization, Frequency, Statistics, Regionalization, Names of clinical conditions and procedures 135 studies 27 different conditions and procedures Hospital (or physician) volume as independent variable Health outcomes as dependent variable Ref: Ann of Int Med 136(2) 2002 Conclusions Variability in methodology + definitions 88% of studies performed risk adjustment 70% found a significant relationship between volume and better outcome Relationship varied by condition and procedure Most notable in pancreatic and esophageal cancer surgery, pediatric cardiac surgery, ruptured AAA, AIDS Surgeon volume more important than hospital volume in CABG, carotid endarterectomy, AAA, and colorectal surgery Volume NOT predictive of outcome for individual hospitals or physicians Ref: Ann of Int Med 136(2)
13 13
14 Design Sources Medicare National Inpatient Sample 6 cardiovascular procedures and 8 cancer surgeries (2.5 million cases) Statistical regression to describe relationship between hospital volume and in-hospital or 30-day mortality Risk-adjustment Ref: NEJM 346(15)
15 Conclusions Patients undergoing many types of procedures can substantially improve their odds of survival by selecting a high-volume hospital Ref: NEJM 346(15) 2002 Design Medicare ( ) 4 cardiovascular procedures and 8 cancer surgeries (474,108 cases) Statistical regression to describe relationship between surgeon volume and in-hospital or 30-day mortality Risk-adjustment Ref: NEJM 349(22)
16 16
17 Conclusions Associations between hospital volume and operative mortality largely mediated by surgeon volume Ref: NEJM 349(22)
18 Design National Cancer Database ( ) 243,103 patients Surgery for M0 colon, esophageal, liver, lung, gastric, pancreatic, or rectal cancer ( ) Impact of hospital volume on: 60-day mortality 5-year conditional survival 18
19 Urologic Malignancies Survival Complications Cancer control QOL Costs Outcomes 19
20 Design Systematic review (MEDLINE, EMBASE, HMIC, Cochrane) 11 North American studies Prostate Bladder Kidney Primary outcome was mortality in 9/11 studies Case mix adjustment RRP outcomes (4 studies) mortality with hospital volume (2/3 studies) mortality with surgeon volume (1 study) Radical cystectomy outcomes (4 studies) mortality with hospital volume (1/3 studies) LOS with hospital volume (1 study) mortality with surgeon volume (1 study) Radical nephrectomy outcomes (4 studies) mortality with hospital volume (1 study) No change (1 study) mortality with hospital volume (1 study) 20
21 Design MEDLINE systematic review ( ) Prostate Bladder Kidney Testis 21
22 Prostate Bladder 22
23 Kidney Testis 23
24 Prostate Design 11,522 consecutive RRPs from SEER-Medicare database ( ) Ref: NEJM 346(15)
25 25
26 Design surgeons at 2 large urban centers (MSKCC and Baylor) 4,629 patients with ct1-t3nxmo CaP 1 outcome = surgical margin status 26
27 Findings 26 surgeons > 10 RRPs during the study period Positive margins 10-48% Predictors based on multivariate analysis PSA ECE level Pathologic Gleason score Surgery date Surgical volume Surgeon 27
28 Design 5,238 consecutive RRP from SEER-Medicare database ( ) 159 high-volume surgeons ( 20 RRP / 5 yr) 16% performed 48.7% of RRPs Adjustment for hospital volume, surgeon volume, and case mix Findings 30-day mortality = 0.5% Major post-op complication rate = 28.6% Late urinary complication rate = 25.2% Long-term incontinence = 6.7% Variation in rate of complications greater than expected by chance even after adjusting for covariates (p = 0.001) 28
29 29
30 30
31 Design Systematic review ( ) Meta-analysis of Observational Studies in Epidemiology Inclusion criteria Controlled studies English language Patient outcomes related to hospital/surgeon RRP volume 17 studies Ref: JU 180 Sept 2008 Findings Hospital volume > mean (43 RRP / yr) Mortality RR 0.62 (0.47 to 0.81) Morbidity 9.7% (-15.8 to -3.6%) Teaching hospitals Surgical complications 18% (-26 to -9%) Surgeon volume Not associated with mortality or margin status Incontinence 1.2% (-2.5 to -0.1) for each additional 10 RRP / yr LOS Ref: JU 180 Sept
32 32
33 Design 1 st 100 consecutive patients undergoing dvp (Feb 2003 Aug 2005) Single center with same surgical team 33
34 Conclusions Experience with dvp leads to a decrease in positive surgical margins especially at the apex and bladder neck Learning curves with new techniques may affect and predict oncologic outcomes Approximately 30 cases are needed to gain proficiency 34
35 Design 2,702 RRP from 5% national Medicare sample ( ) Ref: Oncology
36 CUOG P95A Multicenter Canadian study n = 549 CaP patients Randomized NHT 3 vs. 8 mo prior to RRP 1 Outcome = PSA recurrence Subset analysis Hospital volume 36
37 37
38 Bladder 38
39 Design Nationwide Inpatient Sample (NIS) with ICD-9 codes 1,847 patients who underwent radical cystectomy for bladder cancer in 2003 Multivariate analysis of measures of hospital structure in HV vs. LV Capacity Staffing Health services Models used to determine impact of these variables on the volumeoutcome relationship Ref: JU 177 June 2007 Findings Substantial differences in hospital structure and resources Post-op mortality 3.2X at LV centers Ref: JU 177 June
40 Improved access to diagnostic services Oncology Radiology 40
41 Improved access to interventional services ICU Interventional Radiology Hemodialysis Chemo Palliative care Pain management at HV centers Design Healthcare Utilization Project Nationwide Inpatient Sample ( ) All inpatient discharges for radical cystectomy 41
42 42
43 Design Nationwide Inpatient Sample 22,088 radical cystectomies for CaB ( ) Findings >90% of surgeries performed in urban centers >45% of surgeries performed in teaching centers 43
44 Plausibility Consistent relationship seen over time and across studies Relationship is clinically plausible Likely that surgeons specialized in specific procedures will have better outcomes Consistent postoperative care at HV centers More access to diagnostic + interventional resources Radiology ICU CCU etc. Criticisms Observational studies Medicare data Readily available + inexpensive Population 65 May not give accurate representation of hospital/surgeon volume Differences in data quality across hospitals Problems with establishing timing of events Risk stratification to account for differences in patient populations Volume is an imperfect proxy for quality 44
45 Solutions 1. Regionalization ( Centers of Excellence ) Potentially jeopardizes medical services provided in affected regions Financial + logistic difficulties for patients + families Loss of continuity of care Difficulty recruiting + retaining surgeons in low-volume centers 2. Quality improvement initiatives based on an analysis of what is done differently at those centers with better outcomes Conclusions Growing interest in health-outcomes research and accountability A direct association exists between provider volume and improved outcomes The magnitude of the association varies according to the procedure The quality of the surgeon cannot be judged solely by volume Solutions include regionalization or quality improvement initiatives Further research is needed 45
46 Thank You 46
Concentration and choice in the provision of hospital services: summary report NHS Centre for Reviews and Dissemination
Concentration and choice in the provision of hospital services: summary report NHS Centre for Reviews and Dissemination Authors' objectives To undertake systematic reviews of the literature on the relationship
More informationRelationship between surgical volume and patient outcomes
7 Relationship between surgical volume and patient outcomes MASSIMILIANO SPALIVIERO AND JAMES A. EASTHAM The authors discuss the inverse relationship between hospital volume of surgical procedures and
More informationThe Harvard community has made this article openly available. Please share how this access benefits you. Your story matters
A Contemporary, Population-Based Analysis of the Incidence, Cost, Outcomes, and Preoperative Risk Prediction of Postoperative Delirium Following Major Urologic Cancer Surgeries The Harvard community has
More informationby the average mortality reductions that plausibly could be achieved with regionalization.
Potential Benefits of Regionalizing Major Surgery in Medicare Patients CONTEXT. Given the strong volume outcome relations observed with many surgical procedures, concentrating surgery in high-volume hospitals
More informationComparative Effectiveness Research of Robotic Surgeries for Cancer Treatment
Comparative Effectiveness Research of Robotic Surgeries for Cancer Treatment Jim C. Hu MD, MPH Ronald Lynch Professor in Urologic Oncology Director of the LeFrak Center for Robotic Surgery 1 Objectives
More informationPresentation with lymphadenopathy
Presentation with lymphadenopathy Theo M. de Reijke MD PhD FEBU Department of Urology Academic Medical Center Amsterdam Rationale for RRP in N+ disease Prevention local problems Better survival in limited
More informationComplications in robotic surgery!! Review of the literature! RALP, RAPN and RARC!
Complications in robotic surgery Review of the literature RALP, RAPN and RARC Anna Wallerstedt, MD Karolinska University Hospital Stockholm, Sweden Agenda The importance of reporting surgical complications
More informationProstate Cancer Incidence
Prostate Cancer: Prevention, Screening and Treatment Philip Kantoff MD Dana-Farber Cancer Institute Professor of fmedicine i Harvard Medical School Prostate Cancer Incidence # of patients 350,000 New Cases
More informationOpioid use and over-prescription in post-operative patients. Opioid Epidemic. Opioid Epidemic 6/5/2017. epidemic?
Opioid use and over-prescription in post-operative patients Eric Chen, MD/PhD Department of Orthopaedic Surgery Boston University / Boston Medical Center Lahey Hospital Medical Center Opioid Epidemic Nationwide
More informationTechnical Appendix for Outcome Measures
Study Overview Technical Appendix for Outcome Measures This is a report on data used, and analyses done, by MPA Healthcare Solutions (MPA, formerly Michael Pine and Associates) for Consumers CHECKBOOK/Center
More informationReview on Tumour Doubling Time (DT) To review the studies that measuring the actual tumour doubling time for human cancers.
Review on Tumour Doubling Time (DT) Objective To review the studies that measuring the actual tumour doubling time for human cancers. Methods We searched the Medline database from January 1966 to January
More informationBest Papers. F. Fusco
Best Papers UROLOGY F. Fusco Best papers - 2015 RP/RT Oncological outcomes RP/RT IN ct3 Utilization trends RP/RT Complications Evolving role of elnd /Salvage LND This cohort reflects the current clinical
More informationPresentation with lymphadenopathy
Presentation with lymphadenopathy Theo M. de Reijke MD PhD FEBU Department of Urology Academic Medical Center Amsterdam Rationale for RRP in N+ disease Prevention local problems Better survival in limited
More informationBelow is summarised some of the tools and papers that are worth looking at if you have an interest in the area.
What happens to the high risk patients who don t die? Perioperative SIG meeting PBLD Noosa 2015 Nicola Broadbent, Auckland, NZ In the process of writing this problem based learning discussion I have read
More informationProstate Cancer Dashboard
Process Risk Assessment Risk assessment: family history assessment of family history of prostate cancer Best Observed: 97 %1 ; Ideal Benchmark:100% measure P8 2 Process Appropriateness of Care Pre-treatment
More informationDebate: Adjuvant vs. Neoadjuvant Therapy for Urothelial Cancer
Debate: Adjuvant vs. Neoadjuvant Therapy for Urothelial Cancer Kala Sridhar, MD, MSc, FRCPC Medical Oncologist, Princess Margaret Hospital GU Medical Oncology Site Group Head Associate Professor, University
More informationSupplementary Online Content
Supplementary Online Content Henson KE, Brock R, Charnock J, Wickramasinghe B, Will O, Pitman A. Risk of suicide after cancer diagnosis in England. JAMA Psychiatry. Published online November 21, 2018.
More informationLaparoscopic Surgery. The Da Vinci Robot. Limits of Laparoscopy. What Robotics Offers. Robotic Urologic Surgery: A New Era in Patient Care
Laparoscopic Surgery Robotic Urologic Surgery: A New Era in Patient Care Laparoscopic technique was introduced in urologic surgery in the 1990s Benefits: Improved recovery time, decreased morbidity Matthew
More informationUsing claims data to investigate RT use at the end of life. B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center
Using claims data to investigate RT use at the end of life B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center Background 25% of Medicare budget spent on the last year of life.
More informationda Vinci Prostatectomy
da Vinci Prostatectomy Justin T. Lee MD Director of Robotic Surgery Urology Associates of North Texas (UANT) USMD Prostate Cancer Center (www.usmdpcc.com) Prostate Cancer Facts Prostate cancer Leading
More informationPotential disruption from private exchanges and narrow networks. In 2011, less than 10% of companies used High Performing Networks (narrow networks)
1 3 2 Potential disruption from private exchanges and narrow networks. In 2011, less than 10% of companies used High Performing Networks (narrow networks) and in 2014 estimated to be 40%. By 2018, that
More informationCaring for Survivors. Nancy Houlihan, RN, MA, AOCN. Cancer Survivorship Program
Caring for Survivors Nancy Houlihan, RN, MA, AOCN Cancer Survivorship Program Survivors Growing numbers of survivors Convergance of ageing population and numbers surviving cancer Greatest number are over
More informationThe Society for Vascular Surgery Patient Safety Organization: Use of A Quality Registry for Practice Improvement
The Society for Vascular Surgery Patient Safety Organization: Use of A Quality Registry for Practice Improvement Georgia Vascular Society Adam W. Beck, MD, FACS September 9, 2017 Disclosures No relevant
More informationLoss of Independence is associated with readmission and delayed death in older surgical patients
Loss of Independence is associated with readmission and delayed death in older surgical patients @BerianJulia July 18, 2016 ACS NSQIP 2016 Annual Meeting Julia R. Berian MD,MS; Clifford Y. Ko MD,MS,MSHS;
More informationCHEMO-RADIOTHERAPY FOR BLADDER CANCER. Dr Darren Mitchell Consultant Clinical Oncologist Northern Ireland Cancer Centre
CHEMO-RADIOTHERAPY FOR BLADDER CANCER Dr Darren Mitchell Consultant Clinical Oncologist Northern Ireland Cancer Centre AIMS Muscle invasive disease Current Gold-Standard Rationale behind Chemo-Radiotherapy
More informationDepartment of Urology, Cochin hospital Paris Descartes University
Technical advances in the treatment of localized prostate cancer Pr Michaël Peyromaure Department of Urology, Cochin hospital Paris Descartes University Introduction Curative treatments of localized prostate
More informationGenital Trauma *************************** Ureteral Trauma
Genital Trauma September 26>, Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily 1 exp genital injury/ (4099) 2 (penis/ or testis/ or vagina/) and (blunt trauma/ or penetrating
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Adenocarcinoma, pancreatic ductal, laparoscopic distal pancreatectomy for, 61 Adrenal cortical carcinoma, laparoscopic adrenalectomy for, 114
More informationSurgical treatment of intact thoracoabdominal aortic aneurysms in the United States: Hospital and surgeon volume-related outcomes
Surgical treatment of intact thoracoabdominal aortic aneurysms in the United States: Hospital and surgeon volume-related outcomes John A. Cowan, Jr, MD, a Justin B. Dimick, MD, a Peter K. Henke, MD, a
More informationMultilevel correlates of inhospital mortality among head and neck cancer patients
Multilevel correlates of inhospital mortality among head and neck cancer patients Eric Adjei Boakye, MA 1, Nosayaba Osazuwa-Peters, BDS, MPH, CHES 2, Betelihem B Tobo, MPH 1, Christian J Geneus, MS, MPH
More informationBest Practices for Fast Track in Bariatric Surgery: Enhanced Recovery After Bariatric Surgery
Best Practices for Fast Track in Bariatric Surgery: Enhanced Recovery After Bariatric Surgery Abdelrahman Nimeri, MBBCh, FACS, FASMBS ACS NSQIP Surgeon Champion Chief of General, Thoracic & Vascular Surgery
More informationPalliative Care for Older Adults in the United States
Palliative Care for Older Adults in the United States Nathan Goldstein, MD Associate Professor Hertzberg Palliative Care Institute Brookdale Department of Geriatrics and Palliative Medicine Icahn School
More informationAmerican hospitals crawling towards Electronic Medical Records (EMR) and Computerized Physician Order Entry (CPOE)
Welcome! American hospitals crawling towards Electronic Medical Records (EMR) and Computerized Physician Order Entry (CPOE) Still
More informationAanvraag gegevens ten behoeve van wetenschappelijk onderzoek
Aanvraag gegevens ten behoeve van wetenschappelijk onderzoek Registatie waarvan gegevens worden opgevraagd: NBCA Contactpersoon Nederland: Naam: Dr. A.C.M. van Bommel of Dr. H.A. Rakhorst Centrum/Ziekenhuis:
More informationHealth Services & High Risk Admissions Registries. David Carnahan, MD MSCE DHA CEI Branch Chief 12 June 2014
Health Services & High Risk Admissions Registries David Carnahan, MD MSCE DHA CEI Branch Chief 12 June 2014 Introduction Background Information Variables of Interest (potential markers) ACG Use case Readmissions
More informationWhen radical prostatectomy is not enough: The evolving role of postoperative
When radical prostatectomy is not enough: The evolving role of postoperative radiation therapy Dr Tom Pickles Clinical Associate Professor, UBC. Chair, Provincial Genito-Urinary Tumour Group BC Cancer
More information3.1 Investigations for Patients Presenting with Haematuria Table 1
3.1 Investigations for Patients Presenting with Haematuria Table 1 Patients at risk of bacterial endocarditis should be given antibiotic prophylaxis as per local guidelines. Patients with heart valve replacements
More informationQUALITY INDICATORS FOR UPPER GI CANCER
QUALITY INDICATORS FOR THE MANAGEMENT OF UPPER GI CANCER J. Vlayen, C. De Gendt, S. Stordeur, V. Schillemans, C. Camberlin, F. Vrijens, E. Van Eycken, T. Lerut KCE Report 200 Slides show Background Upper
More informationThe Influence of Surgeon Specialty on Outcomes in General Thoracic Surgery: A National Sample 1996 to 2005
The Influence of Surgeon Specialty on Outcomes in General Thoracic Surgery: A National Sample 1996 to 2005 Paul H. Schipper, MD, Brian S. Diggs, PhD, Ross M. Ungerleider, MD, MBA, and Karl F. Welke, MD,
More informationPatient Selection for Surgery in RCC with Thrombus. E. Jason Abel, M.D.
Patient Selection for Surgery in RCC with Thrombus E. Jason Abel, M.D. RCC with venous invasion Venous invasion occurs in ~10% of RCC Surgery more complex Increased risk for morbidity Thrombus may be confined
More informationWhen PSA fails. Urology Grand Rounds Alexandra Perks. Rising PSA after Radical Prostatectomy
When PSA fails Urology Grand Rounds Alexandra Perks Rising PSA after Radical Prostatectomy Issues Natural History Local vs Metastatic Treatment options 1 10 000 men / year in Canada 4000 RRP 15-year PSA
More informationDetection & Risk Stratification for Early Stage Prostate Cancer
Detection & Risk Stratification for Early Stage Prostate Cancer Andrew J. Stephenson, MD, FRCSC, FACS Chief, Urologic Oncology Glickman Urological and Kidney Institute Cleveland Clinic Risk Stratification:
More informationImpact of Screening Colonoscopy on Outcomes in Colon Cancer Surgery
Impact of Screening Colonoscopy on Outcomes in Colon Cancer Surgery The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation
More informationPancreaticoduodenectomy
Pancreaticoduodenectomy A Valuable Surgery Paul Montero PGY-III September 11, 2006 Overview Brief History Perils of Early Pancreaticoduodenectomy (PD) Improvements Quality of Life after PD Widened Indications
More informationOne Stop Prostate Biopsy Protocol Author Consultation Date Approved
One Stop Prostate Biopsy Protocol Author Consultation Date Approved Urology Nurse Practioner PROTOCOL FOR MEN ATTENDING A ONE STOP PROSTATE BIOPSY CLINIC RATIONALE Prostate cancer is the most common cancer
More informationThe Royal Marsden. Prostate case study. Presented by Mr Alan Thompson Consultant Urological Surgeon
Prostate case study Presented by Mr Alan Thompson Consultant Urological Surgeon 2 Part one Initial presentation A 62 year old male solicitor attends your GP surgery. He has rarely seen you over the last
More informationBariatric Surgery: A Cost-effective Treatment of Obesity?
Bariatric Surgery: A Cost-effective Treatment of Obesity? Shaneeta M. Johnson MD FACS FASMBS 2018 NMA Professional Development Seminar Congressional Black Caucus Foundation Annual Legislative Conference
More informationCardiovascular Disease and Commercial Motor Vehicle Driver Safety. Physical Qualifications Division April 10, 2007
Federal Motor Carrier Safety Administration Executive Summary Cardiovascular Disease and Commercial Motor Vehicle Driver Safety Presented to Physical Qualifications Division April 10, 2007 Prepared by:
More informationRelationship between surgeon volume and outcomes: a systematic review of systematic reviews
Morche et al. Systematic Reviews (2016) 5:204 DOI 10.1186/s13643-016-0376-4 RESEARCH Open Access Relationship between surgeon volume and outcomes: a systematic review of systematic reviews Johannes Morche
More informationPSA is rising: What to do? After curative intended radiotherapy: More local options?
Klinik und Poliklinik für Urologie und Kinderurologie Direktor: Prof. Dr. H. Riedmiller PSA is rising: What to do? After curative intended radiotherapy: More local options? Klinische und molekulare Charakterisierung
More informationMr Declan Cahill Consultant Urological Surgeon The Royal Marsden
Diagnosing prostate cancer Mr Declan Cahill Consultant Urological Surgeon 2 Marsden GP Education Day 22 February 2016 Should I have a PSA test? Can I have a PSA test? prostatecanceruk.org 4 83% raised
More informationPredictive Models. Michael W. Kattan, Ph.D. Department of Quantitative Health Sciences and Glickman Urologic and Kidney Institute
Predictive Models Michael W. Kattan, Ph.D. Department of Quantitative Health Sciences and Glickman Urologic and Kidney Institute Treatment for clinically localized prostate cancer Trade off: Substantial
More information2016 OPAM Mid-Year Educational Conference, sponsored by AOCOPM Thursday, March 10, 2016 C-1
Long-term Outcomes of Lumbar Fusion Among Workers Compensation Subjects : An Historical Cohort Study Trang Nguyen M.D., Ph.D. David C. Randolph M.D, M.P.H. James Talmage MD Paul Succop PhD Russell Travis
More informationPredictors of use of orthotopic bladder reconstruction after radical cystectomy for bladder cancer: Data from a pilot study of 2414 cases
Predictors of use of orthotopic bladder reconstruction after radical cystectomy for bladder cancer: Data from a pilot study of 2414 cases 2004-2010 Luke Hounsome 1, Gary Abel 2, Julia Verne 1, David Neal
More informationAn Undergraduate Syllabus for Urology. Produced on behalf of the British Association of Urological Surgeons. March 2012
An Undergraduate Syllabus for Urology Produced on behalf of the British Association of Urological Surgeons March 2012 Authors H Hashim, P Jones, KJ O Flynn, I Pearce, J Royle, M Shaw, AM Sinclair Correspondence
More informationLeveraging Your Cancer Registry: A Strategy for Survey Success
CoC-trained consultants on staff Leveraging Your Cancer Registry: A Strategy for Survey Success Toni Hare, RHIT, CTR CoC-trained Consultant Vice President, CHAMPS Oncology November 27, 2012 Georgia s Best
More informationOverview...3. Cancer Program.4. Breast Cancer with 5-year Survival Analysis...6. Systemic Therapy.7. Stage of Breast Cancer Diagnosed in
2011 Annual Report Table Of Contents Overview...3 Cancer Program.4 Breast Cancer with 5-year Survival Analysis...6 Systemic.7 Stage of Breast Cancer Diagnosed in 2008..8 Radiation and Systemic Only...9
More informationUnderstanding the risk of recurrence after primary treatment for prostate cancer. Aditya Bagrodia, MD
Understanding the risk of recurrence after primary treatment for prostate cancer Aditya Bagrodia, MD Aditya.bagrodia@utsouthwestern.edu 423-967-5848 Outline and objectives Prostate cancer demographics
More informationFactors Associated with Initial Treatment for Clinically Localized Prostate Cancer
Factors Associated with Initial Treatment for Clinically Localized Prostate Cancer Preliminary Results from the National Program of Cancer Registries Patterns of Care Study (PoC1) NAACCR Annual Meeting
More informationNICaN workshop: Colorectal Cancer Follow-up
NICaN workshop: Colorectal Cancer Follow-up The Changing Picture of Colorectal Cancer in Northern Ireland Dr Helen Coleman Lecturer in Cancer Epidemiology & CRUK Population Research Postdoctoral Fellow
More informationHealth Screening Update: Prostate Cancer Zamip Patel, MD FSACOFP Convention August 1 st, 2015
Health Screening Update: Prostate Cancer Zamip Patel, MD FSACOFP Convention August 1 st, 2015 Outline Epidemiology of prostate cancer Purpose of screening Method of screening Contemporary screening trials
More informationThe Use of Clinical Trial Data in Combination with External Data Sources to Examine Novel Cancer Research Questions: A Modified Big Data Approach
The Use of Clinical Trial Data in Combination with External Data Sources to Examine Novel Cancer Research Questions: A Modified Big Data Approach Joseph Unger, Ph.D. Assistant Member, Public Health Sciences
More informationCancer. Description. Section: Surgery Effective Date: October 15, 2016 Subsection: Original Policy Date: September 9, 2011 Subject:
Subject: Saturation Biopsy for Diagnosis, Last Review Status/Date: September 2016 Page: 1 of 9 Saturation Biopsy for Diagnosis, Description Saturation biopsy of the prostate, in which more cores are obtained
More informationAnal Sphincter Injuries: Acute Management
Anal Sphincter Injuries: Acute Management Dr Stephen Jeffery Urogynaecology Consultant Department of Obstetrics & Gynaecology Groote Schuur Hospital Colorectal Surgeons Gynaecologists Gynaecologists Colorectal
More informationProviding Treatment Information for Prostate Cancer Patients
Providing Treatment Information for Prostate Cancer Patients For all patients with localized disease on biopsy For all patients with adverse pathology after prostatectomy See what better looks like Contact
More informationT3 NSCLC: Chest Wall, Diaphragm, Mediastinum
for T3 NSCLC: Chest Wall, Diaphragm, Mediastinum AATS Postgraduate Course April 29, 2012 Thomas A. D Amico MD Professor of Surgery, Chief of Thoracic Surgery Duke University Health System Disclosure No
More informationPhase-specific Costs of Cancer Care in Ontario
Phase-specific Costs of Cancer Care in Ontario Canadian Association of Health Services and Policy Research Conference Session: D5 Cancer Care Wednesday May 29 2013 Claire de Oliveira, M.A. PhD Background
More informationHow much colon should be resected?
Colon Cancer Surgical Standard of Care and Operative Techniques Madhulika G. Varma MD Professor and Chief Section of Colorectal Surgery University of California, San Francisco How much colon should be
More informationGSK Medicine: Study Number: Title: Rationale: Study Period: Objectives: Indication: Study Investigators/Centers: Research Methods: Data Source
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationGastrointestinal Multidisciplinary Cancer (GI MDC) Navigation May 3, 2012
Gastrointestinal Multidisciplinary Cancer (GI MDC) Navigation May 3, 2012 Coralyn Martinez MSN, RN, OCN GI Nurse Navigator The Lacks Cancer Center Saint Mary s Health Care Grand Rapids, MI History of
More informationOpen Prostatectomy is Best
Open Prostatectomy is Best William J. Catalona, M.D. The Trifecta Trifecta Cure Continence Potency Northwestern University Feinberg School of Medicine Eastham, J et al, JUrol 179:2207 Continence (Pad Free
More informationNorthern Ireland Prostate Cancer Service
Northern Ireland Prostate Cancer Service Chris Hagan Consultant Urologist Clinical Director Urology and Transplant Belfast Trust (on behalf of Mr Nambi Rajan, NICaN Clinical Lead for Urology) Incidence
More informationBladder Cancer: Long-Term Survival With Metastatic Disease Case Reports and Review of the Literature. William Julian, MD. James J.
Bladder Cancer: Long-Term Survival With Metastatic Disease Case Reports and Review of the Literature William Julian, MD James J. Stark, MD, FACP Maryview Medical Center February 20, 2009 Dr. Julian to
More informationChemotherapy for Urological Cancers
Chemotherapy for Urologic Cancers Matthew Rettig, MD Associate Professor Department of Medicine Division of Hematology-Oncology Department of Urology Medical Director, Prostate Cancer Program Institute
More informationPatient and Hospital Characteristics Associated with Nephron-Sparing Surgery for Small, Localized Kidney Cancers in California,
Patient and Hospital Characteristics Associated with Nephron-Sparing Surgery for Small, Localized Kidney Cancers in California, 2012-2015 Brenda M. Giddings, M.A. California Cancer Reporting and Epidemiologic
More informationChristopher Okunseri, BDS, MSc, MLS, DDPHRCSE, FFDRCSI, Elaye Okunseri, MBA, MSHR, Thorpe JM, PhD., Xiang Qun, MS.
Dental Health Services Research Team Christopher Okunseri, BDS, MSc, MLS, DDPHRCSE, FFDRCSI, Elaye Okunseri, MBA, MSHR, Thorpe JM, PhD., Xiang Qun, MS., Aniko Szabo, PhD Research Support: National Institute
More informationROBOTIC VS OPEN RADICAL CYSTECTOMY
ROBOTIC VS OPEN RADICAL CYSTECTOMY A REVIEW Colin Lundeen December 14, 2016 Objectives Review the history of radical cystectomy Critically analyze recent RCTs comparing open radical cystectomy (ORC) to
More informationA Comprehensive Cancer Center Designated by the National Cancer Institute
N C I C C C A Comprehensive Cancer Center Designated by the National Cancer Institute Screening and Early Detection of Lung Cancer: Ready for Practice? David S. Ettinger, MD, FACP, FCCP Alex Grass Professor
More informationTreatment of Invasive Bladder Cancer in the Elderly and Frail Pa9ent
Treatment of Invasive Bladder Cancer in the Elderly and Frail Pa9ent Jehonathan H Pinthus MD, Ph.D, FRCSC Associate Professor Department of Surgery/Urology McMaster University Life expectancy Current age
More informationCASE CONFERENCE. Supervisor: 常傳訓主任 Reporter: PGY 謝孟廷
CASE CONFERENCE Supervisor: 常傳訓主任 Reporter: PGY 謝孟廷 104-7-5 PATIENT PROFILE Chart No. OOOOOOO Name: OOO Gender: Female Age: 84 y/o Admission date: 2015/10/7 ~ 2015/10/14 xxxx/xx xxxx GIST, midbody, lesser
More informationParadigm Shift in Surgical Training with Robotic Surgery and New Technology
Paradigm Shift in Surgical Training with Robotic Surgery and New Technology Reza Ghavamian MD Professor and Director of Urologic Oncology Department of Urology Montefiore Medical Center Albert Einstein
More informationDemands and Perspectives of Hadron Therapy
Demands and Perspectives of Hadron Therapy Alexander Lin, M.D. Assistant Professor University of Pennsylvania Direction of Operations Roberts Proton Therapy Center Disclosures Teva Pharmaceuticals: Advisory
More informationWho are Candidates for Laparoscopic or Open Radical Nephrectomy. Arieh Shalhav
Who are Candidates for Laparoscopic or Open Radical Nephrectomy Arieh Shalhav Fritz Duda Chair of Urologic Surgery Professor of Surgery and the Comprehensive Cancer Research Center Who are Candidates for
More informationreceive adjuvant chemotherapy
Women with high h risk early stage endometrial cancer should receive adjuvant chemotherapy Michael Friedlander The Prince of Wales Cancer Centre and Royal Hospital for Women The Prince of Wales Cancer
More informationAttachment #2 Overview of Follow-up
Attachment #2 Overview of Follow-up Provided below is a general overview of follow-up and this may vary based on specific patient or cancer characteristics. Of note, Labs and imaging can be performed closer
More information2/28/2010. The 3rd Asian Heart & Vascular Symposium. The 3rd Asian Heart & Vascular Symposium. Quality indicator
The 3rd Asian Heart & Vascular Symposium The 3rd Asian Heart & Vascular Symposium A Quality Study of CABG Surgery in Asian Americans in California What have we learnt? Diana Lau, RN, PhD, CNS Administrative
More informationNewer Aspects of Prostate Cancer Underwriting
Newer Aspects of Prostate Cancer Underwriting Presented By: Jack Swanson, M.D. Keith Hoffman, NFP Moments Made Possible Objectives To review and discuss Conflicting messages about PSA testing Cautions
More informationMitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia
Mitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia Disclosures Edwards Lifesciences Consultant Abbott Mitraclip Royalties
More informationFaster Cancer Treatment Indicators: Use cases
Faster Cancer Treatment Indicators: Use cases 2014 Date: October 2014 Version: Owner: Status: v01 Ministry of Health Cancer Services Final Citation: Ministry of Health. 2014. Faster Cancer Treatment Indicators:
More informationSaturation Biopsy for Diagnosis and Staging and Management of Prostate Cancer
Saturation Biopsy for Diagnosis and Staging and Management of Prostate Cancer Policy Number: 7.01.121 Last Review: 2/2018 Origination: 8/2006 Next Review: 8/2018 Policy Blue Cross and Blue Shield of Kansas
More informationAMERICAN COLLEGE OF SURGEONS NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM. SAR Models. Vanessa Thompson, PhD
AMERICAN COLLEGE OF SURGEONS NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM SAR Models Vanessa Thompson, PhD ACS NSQIP National Conference General Session: Stats I July 26, 2015 No disclosures Overview
More informationSaturation Biopsy for Diagnosis, Staging, and Management of Prostate Cancer
Saturation Biopsy for Diagnosis, Staging, and Management of Prostate Cancer Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana,
More informationNeoadjuvant vs. Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
Neoadjuvant vs. Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Andrew J. Stephenson, MD, FRCSC, FACS Director, Urologic Oncology Associate Professor of Surgery Glickman Urological and Kidney
More informationDiagnosis and Classification of Prostate Cancer
Patient Information English 32 Diagnosis and Classification of Prostate Cancer The underlined terms are listed in the glossary. prostate biopsy is the only test that can confirm a prostate cancer diagnosis.
More informationSpending estimates from Cancer Care Spending
CALIFORNIA HEALTHCARE FOUNDATION August 2015 Estimating Cancer Care Spending in the California Medicare Population: Methodology Detail This paper describes in detail the methods used by Deborah Schrag,
More informationMinimally invasive surgery in urology oncology. Dr. Tongchai Nakamont 23 Jan 2014
Minimally invasive surgery in urology oncology Dr. Tongchai Nakamont 23 Jan 2014 Urology oncology Renal cell carcinoma ( RCC) Transitional cell carcinoma (TCC) Kidney Ureter Bladder Prostate cancer Urological
More informationZhao Y Y et al. Ann Intern Med 2012;156:
Zhao Y Y et al. Ann Intern Med 2012;156:560-569 Introduction Fibrates are commonly prescribed to treat dyslipidemia An increase in serum creatinine level after use has been observed in randomized, placebocontrolled
More informationPredictors of Palliative Therapy Receipt in Stage IV Colorectal Cancer
Predictors of Palliative Therapy Receipt in Stage IV Colorectal Cancer Osayande Osagiede, MBBS, MPH 1,2, Aaron C. Spaulding, PhD 2, Ryan D. Frank, MS 3, Amit Merchea, MD 1, Dorin Colibaseanu, MD 1 ACS
More informationTHE NATIONAL QUALITY FORUM
THE NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Patient Outcomes Table of Measures Submitted-Phase 1 As of March 5, 2010 Note: This information is for personal and noncommercial use
More informationDisclosures. Overview. Selection the most accurate statement: Updates in Lung Cancer Screening 5/26/17. No Financial Disclosures
Updates in Lung Cancer Screening Disclosures No Financial Disclosures Neil Trivedi, MD Associate Professor of Clinical Medicine SF VAMC Pulmonary and Critical Care Director, Bronchoscopy & Interventional
More information